Profund Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Profund Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259K	Buy	7,844 +1,323	+20%	+$56K	0.01%	855
2025 Q4	$302K	Buy	6,521 +734	+13%	+$30.7K	0.01%	865
2025 Q3	$202K	Buy	+5,787	New	+$201K	0.01%	978
2025 Q2	–	Sell	-7,480	Closed	-$223K	–	1005
2025 Q1	$223K	Sell	7,480 -1,946	-21%	-$59.5K	0.01%	847
2024 Q4	$270K	Buy	9,426 +1,250	+15%	+$41.4K	0.01%	822
2024 Q3	$316K	Sell	8,176 -629	-7%	-$22.4K	0.01%	769
2024 Q2	$284K	Buy	8,805 +3,039	+53%	+$105K	0.01%	746
2024 Q1	$224K	Buy	+5,766	New	+$202K	0.01%	1023

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Profund Advisors's COLL Position: Q1 2026 in Review

Profund Advisors increased its Collegium Pharmaceutical (COLL) stake by 20% in Q1 2026, buying an estimated $56K and bringing the position to 7,844 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #855.

Profund Advisors first reported a position in COLL in Q1 2024 and has held it in 8 quarters since. The position peaked at $316K in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Profund Advisors held 7,844 shares of Collegium Pharmaceutical worth $259K as of Q1 2026.
Profund Advisors bought 1,323 Collegium Pharmaceutical shares in Q1 2026, an estimated $56K.
Collegium Pharmaceutical made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #855 holding.
Profund Advisors first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 8 quarters since.
Profund Advisors's Collegium Pharmaceutical position peaked at $316K in Q3 2024.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.